The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

  • See Evidence submitted by expert panel for details.

Variant: NM_005633.3(SOS1):c.*4C>T

CA181051

177950 (ClinVar)

Gene: SOS1
Condition: RASopathy
Inheritance Mode: Autosomal dominant inheritance
UUID: 35465003-8a5c-4ed0-8a54-1f380f7cad30
Approved on: 2019-11-04
Published on: 2019-11-04

HGVS expressions

NM_005633.3:c.*4C>T
NM_005633.3(SOS1):c.*4C>T
NC_000002.12:g.38985820G>A
CM000664.2:g.38985820G>A
NC_000002.11:g.39212961G>A
CM000664.1:g.39212961G>A
NC_000002.10:g.39066465G>A
NG_007530.1:g.139644C>T
ENST00000395038.6:c.*4C>T
ENST00000402219.6:c.*4C>T
ENST00000426016.5:c.*4C>T

Benign

Met criteria codes 3
BP7 BP4 BA1

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
RASopathy VCEP
The c.*4C>T variant in SOS1 is classified as benign because it has been identified in 0.05383% (95% CI of 27/35402) of Latino alleles in gnomAD (BA1; https://gnomad.broadinstitute.org). It does not alter an amino acid residue, is not located within the splice consensus site, and computational splice prediction tools do not predict an impact on splicing (BP4, BP7). ACMG/AMP Criteria applied: BA1, BP4, BP7.
Met criteria codes
BP7
Intronic variant outside splice consensus sequence, and Alamut predicts no impact on splicing.
BP4
Splicing is not predicted to be impacted in Alamut. REVEL score not provided.
BA1
Present in 0.05383% (95% CI of 27/35402) of Latino alleles in gnomAD
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.